KemPharm Receives Patent Grant for KP606, a Prodrug of Oxycodone
Additional Patent Granted for the KP511-related family, a Prodrug of Hydromorphone CORALVILLE, Iowa, Jan. 23, 2018 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ:KMPH), a clinical-stage specialty pharmaceutical company focused on the discovery and development …